14d
Hosted on MSNImmunotherapy-TACE Regimen Boosts PFS in Unresectable Liver CancerAdding camrelizumab and rivoceranib to transarterial chemoembolization (TACE) significantly prolonged progression-free survival (PFS) in patients with unresectable hepatocellular carcinoma (HCC), ...
2/20 Riverview Street, Emerald is a 3 bedroom house. What are the key property features of 2/20 Riverview Street, Emerald? Explore all key property features for 2/20 Riverview Street, Emerald.
The Emerald City is a particular location in the One Piece world that not many likely care about. However, it most certainly ...
Situated in the Echidna Valley acreage Estate this stunning architecturally designed home has been priced well below replacement cost and should be inspected to appreciate what this outstanding ...
Emerald Waterfront Bar and Grill celebrated its grand opening to the public on Sunday, garnering over 500 attendees. Visitors received oyster samples, craft beer tastings and a taste of what's to ...
Episode 2 of “Cue the Commentary” offers listeners a better understanding as to why Carrie and Big could never seem to let go of each other in Sex and the City, and how their relationship ...
The FDA approved Imfinzi for a similar indication in December 2024. In the past year, shares of AstraZeneca have rallied 7.3% against the industry’s decline of 2.6%. Zacks Investment Research ...
on Wednesday provided an update on its Phase 1b/2 DURIPANC clinical trial evaluating the combination of Ampligen or rintatolimod and Imfinzi or durvalumab in treating late-stage pancreatic cancer.
Median PFS was 16.6 months for Imfinzi versus 9.2 months for placebo. An estimated 46% of patients treated with Imfinzi had not experienced disease progression at two years compared to 34% for ...
Median progression-free survival was 16.6 months for Imfinzi versus 9.2 months for placebo, and an estimated 46% of patients randomised to receive Imfinzi had not experienced disease progression at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results